期刊文献+

Ⅰ_(B)期宫颈癌淋巴结转移临床病理因素及预后分析 被引量:4

Clinicopathological factors and prognostic analysis of lymph node metastasis in stageⅠ_(B)cervical cancer
原文传递
导出
摘要 目的:探讨Ⅰ_(B)期宫颈癌患者淋巴结转移相关危险因素及预后。方法:回顾性分析2014—2016年间中国医学科学院肿瘤医院收治宫颈癌根治手术±术后治疗的305例Ⅰ_(B1)~Ⅰ_(B2)期患者临床资料,其中伴淋巴结转移31例。Logistic回归模型分析影响转移的因素。结果:31例患者中位随访时间36个月,2例复发转移,3年无瘤生存率为94%(29/31);1例死亡,3年总生存率为97%(30/31)。Ⅰ_(B1)期(肿瘤≤4 cm)、Ⅰ_(B2)期(肿瘤>4 cm)淋巴结转移率分别为8.2%(22/267)、24%(9/38)(P<0.01)。淋巴脉管间隙浸润(LVSI)阳性(P<0.01)及宫颈间质浸润深度>1/2(P<0.01)与Ⅰ_(B)期发生淋巴结转移相关。多因素结果显示LVSI阳性(P=0.016)为Ⅰ_(B)期宫颈癌淋巴结转移的独立危险因素。结论:Ⅰ_(B)期宫颈癌患者中肿瘤>4 cm、伴有LVSI及宫颈间质浸润深度>1/2易发生淋巴结转移且LVSI阳性为独立危险因素。Ⅰ_(B)期宫颈癌合并淋巴结转移患者,经根治性手术及术后辅助同步放化疗可以取得较好的疗效。 Objective:To investigate the risk factors and prognosis of lymph node metastasis in patients with stageⅠ_(B)cervical cancer.Methods:From April 2014 to December 2016,the clinical data of 305 patients with stageⅠ_(B1)-Ⅰ_(B2)who were admitted to Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College for radical surgery±postoperative treatment were retrospectively analyzed.Among them,31 cases with lymph node metastasis.Logistic regression model was used to analyze the influencing factors of metastasis.Results:The median follow-up time of patients with lymph node metastasis was 36 months,2 cases with recurrence and metastasis,the 3-year disease-free survival rate was 94%(29/31);1 case died,the 3-year survival rate was 97%(30/31).Logistic regression analysis showed that the lymph node metastasis rates of stage I B1(tumor size≤4 cm)or stage I B2(tumor size>4 cm)were 8.2%(22/267)or 24%(9/38),respectively,with statistical difference(P<0.01).LVSI positive(P<0.01)and cervical stromal infiltration depth>1/2(P<0.01)were associated with lymph node metastasis in stage I B.Multivariate results showed that LVSI positive(P=0.016)was an independent risk factor for lymph node metastasis in stage I_( B )cervical cancer.Conclusions:In patients with stage I_( B )cervical cancer,tumor size>4 cm,with LVSI and cervical interstitial invasion depth>1/2 are prone to lymph node metastasis,and LVSI positive is an independent risk factor.For patients with lymph node metastasis in stage I_( B )cervical cancer,radical surgery and postoperative adjuvant concurrent chemo-radiotherapy can achieve good results.
作者 梁磊磊 曾嘉 姚洪文 安菊生 黄曼妮 李晓光 张蓉 吴令英 Liang Leilei;Zeng Jia;Yao Hongwen;An Jusheng;Huang Manni;Li Xiaoguang;Zhang Rong;Wu Lingying(Department of Gynecology,Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China)
出处 《中华转移性肿瘤杂志》 2020年第4期274-277,共4页 Chinese Journal of Metastatic Cancer
关键词 宫颈癌 淋巴结转移 综合治疗 预后 Cervical cancer Lymph node metastasis Comprehensive treatment Prognosis
作者简介 通信作者:吴令英,Email:wulingying@csco.org.cn
  • 相关文献

参考文献13

二级参考文献99

  • 1石一复,谢辛,陈晓端.子宫颈癌盆腔淋巴结清除数的探讨[J].中国实用妇科与产科杂志,1995,11(5):281-283. 被引量:9
  • 2冯淑瑜,张彦娜,刘建刚.宫颈癌淋巴结转移的高危因素及预后分析[J].癌症,2005,24(10):1261-1266. 被引量:71
  • 3李斌,吴令英,李晓光,张询,章文华,高菊珍.早期子宫颈癌宫旁淋巴结的识别及其临床意义[J].中华妇产科杂志,2006,41(9):608-611. 被引量:30
  • 4Hoffman, Mitchel S, Parsons, et al. Distal external iliac lymph nodes in early cervical cancer. Obstetrics Gynecol, 1999, 94: 391-394.
  • 5Michel G, Morice P, Castaigne D, et al. Lymphatic spread in stage Ⅰ b and Ⅱ cervical carcinoma: anatomy and surgical implications. Obstetrics Gynecol, 1998 ,91:360-363.
  • 6Kodama J, Seki N, Masahiro S, et al. Prognostic factors in stage Ⅰ B-Ⅱ B cervical adenocarcinoma patients treated with radical.hysterectomy and pelvic lymphadenectomy. J Surg Oncol,2010 , 101:413-417.
  • 7Rogers LJ, Luesley DM. Stage IA2 cervical carcinoma: how much treatment is enough? Int~ J Gynecol Cancer, 2009 , 19: 1620-1624.
  • 8Gortzak-Uzan L, Jimenez W, Nofech-Mozes S, et al. Sentinel lymph node biopsy vs. pelvic lymphadenectomy in early stage cervical cancer: is it time to change the gold standard? Gynecol Oncol,2010 ,116:28-32.
  • 9Verheijen R, Pijpers R, Paul J , et al. Sentinel node detection in cervical cancer. Obstetrics Gynecol,2000 , 96 : 135-138.
  • 10Darlin L, Persson J, Bossmar T, et al. The sentinel node concept in early cervical cancer performs well in tumors smaller than 2 cm. Gynecol Oncol, 2010 , 117:266-269.

共引文献507

同被引文献42

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部